School of Medicine
Showing 1-10 of 21 Results
-
Greg Charville, MD, PhD
Assistant Professor of Pathology at the Stanford University Medical Center
Bio Dr. Charville has a special interest in the diagnosis of rare tumors that derive from bone and soft tissues, including muscle, fat, blood vessels, cartilage, and other connective tissues. He also specializes in the classification and study of disorders related to the gastrointestinal and hepatopancreatobiliary systems.
Dr. Charville particularly enjoys working alongside Stanford's excellent physicians-in-training to classify the most diagnostically challenging cases in collaboration with pathologists from around the world, bringing to bear cutting-edge techniques for comprehensive histologic and molecular characterization in each case. This experience serves as the inspiration for laboratory-based investigation of the molecular basis of human disease, focusing on genetic and epigenetic mechanisms of neoplasia. -
Simon Boyi Chen
Affiliate, Dean's Office Operations - Dean Other
Bio I completed an undergraduate degree in Biological Chemistry at the University of Toronto, followed by a medical degree at the Washington University School of Medicine in St. Louis, and residency in Anatomic and Clinical Pathology at Stanford Health Care (SHC). I am currently enrolled in the fellowship program in Molecular Genetic Pathology at SHC, and am slated to complete fellowship training in Surgical Pathology there as well. My interests include oncologic pathology, cardiothoracic pathology, molecular pathology, and applications of artificial intelligence and digital imaging in pathology.
-
Vinita Chittoor
Postdoctoral Research Fellow, Pathology
Current Research and Scholarly Interests Vinita’s work focuses on uncovering the molecular pathobiology of LRRK2 in Parkinson’s disease. Her main project includes understanding the role of proteostatic stress in LRRK2-linked disease, with focus on autophagic dysfunction. Her efforts are also aimed at finding a reliable imaging technique for analyzing post-mortem brains from Parkinson’s disease patients.
